Indero’s biometrics services integrate custom data management and biostatistics to handle complex study designs.
Indero offers deep biometrics insights into a wide range of therapeutic areas, including cardiology, oncology, CNS, respiratory, ophthalmology, rare diseases, endocrinology, dermatology, rheumatology, and gastroenterology.
Data Management
Biostatistics
For 25 years, our biometrics services have consistently been exceeding sponsor expectations with reliability, quality, and expertise. We handle complex study designs across all trial phases, utilizing innovative data analysis techniques and methodologies. Share your data management and biostatistics needs with us today.
Following disappointing results from a phase II CNS trial handled by another CRO, Indero performed a rigorous review of the statistical methodologies and programming algorithms used to analyze the study data, identified flaws, and performed a post-hoc analysis addressing these flaws appropriately yielding statistically significant results and instilling renewed confidence in the drug’s potential for phase III.
“We would definitely collaborate with them again and wholeheartedly recommend their biometrics services.”
Senior VP, Biometrics at Ventyx Biosciences
Wherever You’re Going,
We’re all in.
Need help with your next study? We want to learn more. Fill out the form on the right and one of our experts will be in touch.
3530 Saint-Laurent Boulevard
Suite 300
Montreal, QC, H2X 2V1, Canada
© 2025 Indero. All Rights Reserved. Privacy Policy. Designed and developed by Altitude Marketing.
We are excited to announce that Innovaderm is rebranding our CRO division as Indero (in-dAIR-oh). This rebranding reflects our ongoing commitment to innovation and our expansion into the field of rheumatology, a therapeutic area closely linked to dermatology. As a dual-focus CRO specializing in both dermatology and rheumatology, this strategic decision marks a significant milestone for our organization, and we are eager to embark on this new chapter with our valued partners and clients. Innovaderm will continue to operate as a CRU for dermatology studies.
Our long-standing relationships with key opinion leaders and highly performing sites, result in optimized start-up processes that deliver strong results in the least amount of time. As part of our site evaluation, our team utilizes past performance metrics, recruitment projections based on competitive landscape, and detailed feasibility surveys to determine a site’s capabilities and interest in a study.
Our dedicated patient recruitment and advertising team integrates with the study team to tailor recruitment strategies, customize central ad campaigns, develop advertising creative, and continuously track and adapt recruitment goals. Our patient-centric approach is enhanced by Clinago, our technology enabled recruitment service.
We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.
We orchestrate all study activities and deliverables, including site selection process, budget and contract negotiations, and patient engagement, recruitment enrollment projections, all while respecting your study timelines.
